Quantcast

Latest Prenatal diagnosis Stories

2009-02-09 07:00:00

MENLO PARK, Calif., Feb. 9 /PRNewswire/ -- Artemis Health Inc., a privately-held company dedicated to the development of non-invasive prenatal diagnostic tests, today announced that Richard Rava, Ph.D., has joined Artemis Health in the newly created position of senior vice president of research and development. "Rich's depth and breadth of research, development and manufacturing experience, together with his proven track record in commercializing genetic analysis tools, makes him...

2009-02-05 03:00:00

MINEOLA, N.Y., Feb. 5 /PRNewswire/ -- Lenetix, Inc. today announced the launch of an Institutional Review Board (IRB)-approved screening study of an improved first and second trimester non-invasive fetal diagnostic test to detect Down syndrome. The Lenetix PloidYX(TM) maternal blood test promises to be the most accurate and comprehensive test yet developed for the detection of fetal aneuploidies, the presence of extra chromosomes, which cause Down syndrome (T-21) and other chromosomal...

2009-01-28 20:00:00

Lenetix Announces Successful Study of Improved Non-invasive Test Procedure MINEOLA, N.Y., Jan. 28 /PRNewswire/ -- Lenetix, Inc. today announced a significant step in the development of an improved first and second trimester non-invasive fetal chromosomal screening test to detect Down syndrome and other genetic fetal conditions. Lenetix presented preliminary study results at the 29th annual Society for Maternal-Fetal Medicine Conference in San Diego that indicate a potential breakthrough in...

2009-01-27 07:00:00

-- New Technology May Allow Development of Accurate Blood Test for Common Genetic Disorders Early in Pregnancy -- MENLO PARK, Calif., Jan. 27 /PRNewswire/ -- Artemis Health Inc., a privately-held company dedicated to the development of non-invasive prenatal diagnostic tests, today announced that it has acquired a co-exclusive worldwide license from Stanford University to develop cell-free fetal DNA prenatal diagnostic tests based on pioneering research from the lab of Stephen Quake, Ph.D.,...

4a5586123c8c9d0ee567b44255e821f71
2009-01-26 15:40:00

A new study by researchers at NYU Langone Medical Center found a high desire for additional genetic testing among consumers for life altering and threatening medical conditions including mental retardation, blindness, deafness, cancer, heart disease, dwarfism and shortened lifespan from death by 5 years of age. Consumers, however, are less interested in prenatal genetic testing for traits including tall stature, superior athletic ability and superior intelligence. "Our research has discovered...

2009-01-22 06:00:00

BEIJING, Jan. 22 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Prenatal FISH Probe and Cervical Cancer FISH Probe from the State Food and Drug Administration (the "SFDA") in the People's Republic of China (the "PRC"). The Prenatal FISH Probe is a...

2008-12-23 15:36:00

Two stories of babies born in the unique Special Delivery Unit at The Children's Hospital of Philadelphia, true miracles on 34th Street PHILADELPHIA, Dec. 23 /PRNewswire-USNewswire/ -- Just 6 months after the Garbose Family Special Delivery Unit opened, more than 75 babies have been born and are sharing their first holiday season with their joyful families. Families from 13 states and at least two other countries have traveled to Children's Hospital for expert prenatal care, delivery and...

2008-12-21 13:43:28

Researchers at the Baylor School of Medicine in Houston say they are making breakthroughs in enhanced DNA testing of unborn fetuses. Dr. Arthur Beaudet, head of the school's molecular and human genetics department, said the cutting-edge services being developed at Baylor should be able to reveal previously undetectable disorders in fetuses, the Houston Chronicle reported Saturday. This is the beginning of a sea change in prenatal diagnosis, the research head said. I think it will replace...

f687a60fb331449bd6ab8dbfe6dd40571
2008-11-28 10:15:00

A new national screening strategy in Denmark has halved the number of infants born with Down's syndrome and increased the number of infants diagnosed before birth by 30%, according to a study published on bmj.com today. Many countries, including England, Australia and New Zealand, are trying to introduce national screening strategies for Down's syndrome, but are facing a variety of problems because of a lack of consensus about the screening policy and logistical challenges. In 2004, the...

d9251d368c3cdf1d1329f54f242677cf1
2008-11-25 16:08:39

Researchers claim blood samples taken from expectant mothers may soon reveal if her baby has a wide range of genetic diseases such as cystic fibrosis, thalassaemia and sickle cell anemia. In the past, prenatal diagnoses of such disorders have been possible only through invasive procedures like amniocentesis "” the extraction of a small amount of fluid from the sac surrounding a developing fetus. Such a procedure carries a greater risk of fetal miscarriage. Now, a Chinese University of...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related